To avoid T-cell autoimmunity likely induced by full-length Aβ, we developed a tau vaccine (T294-HBc VLP vaccine) by genetically fusing a B-cell epitope of tau (tau294–305) to HBc MIR. The gene discussed is MAPT; the disease is Autoimmunity.